1321 related articles for article (PubMed ID: 28662118)
21. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF
Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035
[TBL] [Abstract][Full Text] [Related]
22. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of serum iron as a predictor of a hemoglobin response to injectable iron treatment in chronic hemodialysis patients].
Grèze C; Garrouste C; Pereira B; Hadj-Abdelkader M; Heng AÉ; Aniort J
Nephrol Ther; 2022 Dec; 18(7):634-642. PubMed ID: 36216731
[TBL] [Abstract][Full Text] [Related]
24. Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM - HD Study.
Kuo KL; Hung SC; Tseng WC; Tsai MT; Liu JS; Lin MH; Hsu CC; Tarng DC;
J Am Heart Assoc; 2018 Aug; 7(15):e009206. PubMed ID: 30371224
[TBL] [Abstract][Full Text] [Related]
25. Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy.
Caravaca F; Vagace JM; Aparicio A; Groiss J; Pizarro JL; Alonso N; Garcia MC; Arrobas M; Cubero J; Esparrago J
Am J Kidney Dis; 1992 Sep; 20(3):249-54. PubMed ID: 1519605
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
27. Iron indices and intravenous ferumoxytol: time to steady-state.
Kapoian T; O'Mara NB; Carreon M; Gajary A; Rizkala A; Lefavour G; Sherman RA; Walker J
Ann Pharmacother; 2012 Oct; 46(10):1308-14. PubMed ID: 22968523
[TBL] [Abstract][Full Text] [Related]
28. Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation.
Singh AK; Coyne DW; Shapiro W; Rizkala AR;
Kidney Int; 2007 Jun; 71(11):1163-71. PubMed ID: 17396118
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 2-week versus 4-week dosing intervals of epoetin beta pegol on erythropoiesis and iron metabolism in hemodialysis patients.
Morikami Y; Fujimori A; Okada S; Kumei M; Mizobuchi N; Sakai M
Ther Apher Dial; 2014 Oct; 18(5):414-20. PubMed ID: 24456373
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
[TBL] [Abstract][Full Text] [Related]
31. Functional iron deficiency in hemodialysis patients with high ferritin.
Kopelman RC; Smith L; Peoples L; Biesecker R; Rizkala AR
Hemodial Int; 2007 Apr; 11(2):238-46. PubMed ID: 17403177
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
Sany D; El Shahawi Y; Taha J
Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
[TBL] [Abstract][Full Text] [Related]
33. Different Effects of Iron Indices on Mortality in Patients With Autosomal Dominant Polycystic Kidney Disease After Long-Term Hemodialysis: A Nationwide Population-Based Study.
Yeh SC; Lin YC; Hong YC; Hsu CC; Lin YC; Wu MS
J Ren Nutr; 2019 Sep; 29(5):444-453. PubMed ID: 30683605
[TBL] [Abstract][Full Text] [Related]
34. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
Dukkipati R; Kalantar-Zadeh K
Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of iron deficiency anemia in a rural population of children. Relative usefulness of serum ferritin, red cell protoporphyrin, red cell indices, and transferrin saturation determinations.
Hershko C; Bar-Or D; Gaziel Y; Naparstek E; Konijn AM; Grossowicz N; Kaufman N; Izak G
Am J Clin Nutr; 1981 Aug; 34(8):1600-10. PubMed ID: 7270484
[TBL] [Abstract][Full Text] [Related]
36. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients.
Kalantar-Zadeh K; Kleiner M; Dunne E; Ahern K; Nelson M; Koslowe R; Luft FC
Am J Kidney Dis; 1998 Feb; 31(2):263-72. PubMed ID: 9469497
[TBL] [Abstract][Full Text] [Related]
37. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
Anees M; Mumtaz A; Ibrahim M; Shaheen SM; Asghar A
Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306
[TBL] [Abstract][Full Text] [Related]
38. ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage.
Kuragano T; Kitamura K; Matsumura O; Matsuda A; Hara T; Kiyomoto H; Murata T; Fujimoto S; Hase H; Joki N; Fukatsu A; Inoue T; Itakura Y; Nakanishi T
PLoS One; 2016; 11(3):e0147328. PubMed ID: 26933949
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
[TBL] [Abstract][Full Text] [Related]
40. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
